Aurora Cannabis (TSE:ACB) Issues Quarterly Earnings Results

Aurora Cannabis (TSE:ACB) issued its quarterly earnings results on Wednesday. The company reported C($0.07) EPS for the quarter, FiscalAI reports. Aurora Cannabis had a negative return on equity of 7.25% and a negative net margin of 12.13%.The business had revenue of C$67.55 million for the quarter.

Aurora Cannabis Stock Performance

Aurora Cannabis stock traded up C$0.12 on Wednesday, hitting C$4.03. The company’s stock had a trading volume of 584,916 shares, compared to its average volume of 396,689. The company has a fifty day moving average price of C$4.13 and a 200-day moving average price of C$4.66. The firm has a market cap of C$249.63 million, a P/E ratio of -1.88 and a beta of 0.27. Aurora Cannabis has a one year low of C$3.59 and a one year high of C$9.33. The company has a quick ratio of 2.48, a current ratio of 5.94 and a debt-to-equity ratio of 4.66.

Analyst Ratings Changes

A number of brokerages recently issued reports on ACB. TD dropped their target price on shares of Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Canaccord Genuity Group decreased their price target on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research report on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of C$7.17.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.